
KKR & Co. (KKR)
NYSEFinancialsAsset ManagementSnapshot 2026-07-08
Reading KKR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KKR free→
NYSEFinancialsAsset ManagementSnapshot 2026-07-08
Reading KKR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KKR free→QuarterlyIQ Insights · KKR
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 6 valuation methods, at three horizons. Current price $93.29. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
We can't anchor a clean multiple for KKR right now, so treat our $77 fair value as low-confidence (our number sits well below the analyst range). Analysts target $119–$153. Note: our $77 fair value sits below the entire analyst range ($119–$153). The flat-multiple read looks rich, but earnings are inflecting up — trailing growth is accelerating and forward estimates confirm — so we've softened our read rather than brand an accelerating name expensive. Not investment advice.
$119.00 – $153.00 (median $124.00) · 4 analysts · as of 2026-05-06
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Not enough peers to compare yet.
Self-history needs ~20 months of data.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $124.00 | — | — | Analyst | medium |
| ddm gordon | 12M | $16.19 | — | — | TTM | medium |
| Mgmt guidance | 12M | $78.35 | 18.1 | 4.33 | Mgmt | medium |
| Peer P/E | 12M | $92.28 | 18.1 | 5.10 | TTM | medium |
| PEG | 12M | $88.13 | 17.3 | 5.10 | TTM | medium |
| triangulated | 12M | $91.85 | 18.1 | 5.08 | Triangulated | medium |
| Mgmt guidance | 3Y | $165.37 | 18.1 | 9.14 | Mgmt(prov.) | medium |
| Peer P/E | 3Y | $140.34 | 18.1 | 7.76 | Analyst | medium |
| PEG | 3Y | $134.03 | 17.3 | 7.76 | Analyst | medium |
| Mgmt guidance | 5Y | $272.11 | 18.1 | 15.04 | Mgmt(prov.) | medium |
| Peer P/E | 5Y | $185.61 | 18.1 | 10.26 | Analyst | medium |
| PEG | 5Y | $177.26 | 17.3 | 10.26 | Analyst | medium |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.